Form 4: CME Group Director Kathryn Benesh Acquires Shares Through Stock Plan

CME Group Inc. Director Kathryn Benesh acquired 532 shares of common stock at $273.03 per share on June 25, 2025, as part of the company's Director Stock Plan.

Summary

• Kathryn Benesh, a Director at CME Group Inc. (CME), acquired 532 shares of Class A Common Stock.
• The transaction occurred on June 25, 2025, with shares priced at $273.03 each.
• This acquisition was a grant pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this transaction, Ms. Benesh directly beneficially owns 2,106.948 shares of CME Group Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director's acquisition of shares, which can be interpreted as a vote of confidence and alignment with shareholder interests, although it's a routine grant rather than an open market purchase.

Positives

• The acquisition of shares by a director, particularly through a stock plan, can signal alignment of interests between management and shareholders.
• The transaction is part of a pre-existing, disclosed stock plan, indicating a structured approach to director compensation.

Negatives

• No negative information is directly discernible from this Form 4 filing, which primarily reports a routine insider transaction.

Risks

• This Form 4 filing does not contain information regarding specific company risks.

Future Outlook

This Form 4 filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as the acquisition of shares by a director, are common practices in publicly traded companies. These transactions, especially when part of a pre-approved stock plan, are generally viewed as routine compensation mechanisms rather than significant market signals. They reflect the company's compensation strategy for its board members and aim to align their interests with long-term shareholder value.

Corporate Governance

Related Party Transactions

• Kathryn Benesh, as a Director of CME Group Inc., is considered a related party. The acquisition of shares through the CME Group Director Stock Plan constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively as it aligns the director's interests with those of shareholders. However, stock grants can also lead to minor dilution if new shares are issued, though this is typically accounted for in compensation planning.

Next Steps

• This Form 4 filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

CME Group Inc., CME, Form 4, Insider Trading, Stock Acquisition, Director Compensation, Kathryn Benesh, Equity Grant, SEC Filing